India’s Eyestem Raises USD6.4m Series A from Biological E. Limited, Alkem, NATCO, Endiya Partners, Kotak Private Equity, Others
Source(s): Entrackr
Eyestem, an India-based biotech focused on macular degeneration, raised a USD6.4m Series A from Biological E. Limited, Alkem, NATCO, Endiya Partners, Kotak Private Equity and others. Read more